Harry Dao

718 total citations
39 papers, 451 citations indexed

About

Harry Dao is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Harry Dao has authored 39 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Dermatology, 8 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Harry Dao's work include Cutaneous lymphoproliferative disorders research (6 papers), Autoimmune Bullous Skin Diseases (5 papers) and Dermatology and Skin Diseases (5 papers). Harry Dao is often cited by papers focused on Cutaneous lymphoproliferative disorders research (6 papers), Autoimmune Bullous Skin Diseases (5 papers) and Dermatology and Skin Diseases (5 papers). Harry Dao collaborates with scholars based in United States. Harry Dao's co-authors include Daniel J. Lewis, Tara L. Braun, Kevin C.‐W. Wu, Susan Nedorost, Rohit Gupta, Vicky Ren, Walid Kaplan, Anisha B. Patel, Misha Koshelev and Morey W. Haymond and has published in prestigious journals such as The Journal of Urology, Journal of the American Academy of Dermatology and Metabolism.

In The Last Decade

Harry Dao

35 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry Dao United States 12 167 85 58 55 47 39 451
Ömer Kutlu Türkiye 12 226 1.4× 53 0.6× 47 0.8× 17 0.3× 52 1.1× 51 431
Stephanie Chapman United States 12 151 0.9× 98 1.2× 43 0.7× 13 0.2× 96 2.0× 28 443
Benjamin K. Stoff United States 12 98 0.6× 65 0.8× 18 0.3× 25 0.5× 111 2.4× 65 360
Susan Burgin United States 11 185 1.1× 107 1.3× 19 0.3× 19 0.3× 107 2.3× 46 426
Matthew Keller United States 12 179 1.1× 121 1.4× 79 1.4× 15 0.3× 45 1.0× 45 653
Hamid Reza Tohidinik Iran 14 101 0.6× 106 1.2× 29 0.5× 12 0.2× 132 2.8× 38 552
Erin McMeniman Australia 13 106 0.6× 65 0.8× 19 0.3× 43 0.8× 146 3.1× 34 390
Harib Ezaldein United States 12 172 1.0× 80 0.9× 77 1.3× 9 0.2× 154 3.3× 54 554
Peggy L. Lin United States 13 127 0.8× 122 1.4× 44 0.8× 9 0.2× 115 2.4× 33 708

Countries citing papers authored by Harry Dao

Since Specialization
Citations

This map shows the geographic impact of Harry Dao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Dao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Dao more than expected).

Fields of papers citing papers by Harry Dao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Dao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Dao. The network helps show where Harry Dao may publish in the future.

Co-authorship network of co-authors of Harry Dao

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Dao. A scholar is included among the top collaborators of Harry Dao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Dao. Harry Dao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dao, Harry, et al.. (2024). Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab. JAAD Case Reports. 46. 95–99.
2.
Dao, Harry, et al.. (2024). Selecting an iontophoresis device: A source of consternation. Journal of the American Academy of Dermatology. 91(2). 364–366.
3.
Katta, Rajani, et al.. (2023). Practice Efficiency in Dermatology: Enhancing Quality of Care and Physician Well-Being. Cureus. 15(5). e39195–e39195. 2 indexed citations
4.
Dao, Harry, et al.. (2022). Total body skin exams: the role of gynecology and dermatology-a cross-sectional study. Dermatology Online Journal. 28(3). 1 indexed citations
5.
Gupta, Rohit, et al.. (2021). Assessing dermatology resident confidence in caring for patients with skin of color. Clinics in Dermatology. 39(5). 873–878. 14 indexed citations
6.
Gupta, Rohit, et al.. (2021). Evaluating skin of color education in dermatology residency programs: data from a national survey. Clinics in Dermatology. 40(2). 228–233. 9 indexed citations
7.
Ramachandran, Vignesh, Taylor P. Kohn, Nora M. Haney, et al.. (2020). The association of broadband internet access with dermatology practitioners: An ecologic study. Journal of the American Academy of Dermatology. 83(6). 1767–1770. 3 indexed citations
8.
Kohn, Jaden R., et al.. (2020). Clinical outcomes and adherence to topical corticosteroid therapy in women with vulvar lichen sclerosus: A retrospective cohort study. Journal of the American Academy of Dermatology. 83(4). 1104–1109. 11 indexed citations
9.
Wu, Kevin C.‐W. & Harry Dao. (2020). Off-label dermatologic uses of IL-17 inhibitors. Journal of Dermatological Treatment. 33(1). 41–47. 19 indexed citations
10.
Dao, Harry, et al.. (2020). Social Media as a Surveillance Tool for Monitoring of Isotretinoin Adverse Effects. Cureus. 12(9). e10327–e10327. 4 indexed citations
11.
Dao, Harry, et al.. (2020). Dermatology Resident Training on Depression Screening: A Cross-Sectional Survey. Cureus. 12(6). e8861–e8861. 2 indexed citations
12.
Braun, Tara L., et al.. (2019). What are the ethical and legal considerations when your patient refuses the standard of care?. Dermatology Online Journal. 25(8). 1 indexed citations
13.
Gupta, Rohit, et al.. (2019). Failed Treatment of Classic Kaposi’s Sarcoma with Topical Timolol: Case Report and Review of the Literature. Cureus. 11(12). e6272–e6272. 4 indexed citations
14.
Dao, Harry, et al.. (2018). Utilization of voriconazole drug monitoring in the treatment of cutaneous Scedosporium apiospermum infection. Medical Mycology Case Reports. 22. 52–54. 5 indexed citations
15.
Lewis, Daniel J., Harry Dao, Priyadharsini Nagarajan, & Madeleine Duvic. (2017). Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox. JAAD Case Reports. 3(6). 501–504. 12 indexed citations
16.
Pezzi, Todd A., et al.. (2016). Characteristics, treatment, and survival of invasive malignant melanoma (MM) in giant pigmented nevi (GPN) in adults: 976 cases from the National Cancer Data Base (NCDB). Journal of the American Academy of Dermatology. 74(6). 1128–1134. 6 indexed citations
17.
Dao, Harry & Vicky Ren. (2013). Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis. Clinical Cosmetic and Investigational Dermatology. 6. 75–75. 14 indexed citations
18.
Gray, Phillip J., Jingya Wang, Timothy M. Pawlik, et al.. (2012). Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma. Journal of Surgical Oncology. 106(1). 66–71. 7 indexed citations
19.
Dao, Harry, et al.. (2012). Sensitization Prevalence for Benzalkonium Chloride and Benzethonium Chloride. Dermatitis. 23(4). 162–166. 25 indexed citations
20.
Kaplan, Walid, Agneta L. Sunehag, Harry Dao, & Morey W. Haymond. (2008). Short-term effects of recombinant human growth hormone and feeding on gluconeogenesis in humans. Metabolism. 57(6). 725–732. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026